Sulglicotide
Chemical compound
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Sulglicotide (or sulglycotide) is a drug used for peptic ulcer and gastro-oesophageal reflux disease.[1]
References
- ^ Slomiany BL, Piotrowski J, Slomiany A (September 2000). "Omeprazole fails to suppress up-regulation of gastric mucosal endothelin-converting enzyme-1 by Helicobacter pylori lipopolysaccharide" (PDF). J. Physiol. Pharmacol. 51 (3): 421–31. PMID 11016862.
- v
- t
- e
Drugs for peptic ulcer and GERD/GORD (A02B)
- Cimetidine
- Famotidine
- Lafutidine
- Lavoltidine (loxtidine)
- Nizatidine
- Ranitidine#‡
- Roxatidine
analogues ("-prost-")
- Misoprostol
- Enprostil
("-prazole")
- Azeloprazole
- Dexlansoprazole
- Esomeprazole
- Ilaprazole
- Lansoprazole
- Omeprazole#
- Pantoprazole
- Picoprazole
- Rabeprazole
- Tenatoprazole
- Timoprazole
acid blockers ("-prazan")
- Linaprazan
- Revaprazan
- Soraprazan
- Vonoprazan
- See also: Helicobacter pylori eradication protocols
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
![]() | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e